Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

25 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Technetium Tc99m Exametazime Injection Articles

Amersham Pharmacia Biotech Unveiled

11 June 1997

Improving Fundamentals At Amersham Int'l

22 April 1996

Towards Effective Diagnosis Of Alzheimer's Disease

1 April 1996

Amersham's Myoview Gets FDA Go-Ahead

19 February 1996

Amersham Looks Forward To The Future

13 November 1995

Amersham's Growth Slows To 9%

12 June 1995

Amersham's Stabilized Ceretec Approved

17 April 1995

Amersham's 1st Half Disappoints But Strategy Good

14 November 1994

Amersham Bio-Imaging Agreement

17 October 1994

New UK Trials For Amersham's Ceretec

18 July 1994

AMERSHAM'S GOOD RESULTS BOOSTED BY USB

13 June 1994

HALF-YEAR PROFITS UP 71% AT AMERSHAM

15 November 1993

AMERSHAM INT'L FOCUSSED AND GROWING

21 June 1993

MALLINCKRODT'S OCTREOSCAN

7 June 1993

RESTRUCTURING IMPROVES AMERSHAM

15 June 1992

SB WINS QUEEN'S AWARD FOR BACTROBAN

27 April 1992

Showing 1-16 of 16 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
  • Proposal to list Roche's Neulastim and Actemra in New Zealand
  • Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
  • Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
  • Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
  • Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
  • Proposal to list Roche's Neulastim and Actemra in New Zealand
  • Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
  • Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
  • Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS